Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Preemptive Pharmacogenetics in Underserved Patients

NCT05141019 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05141019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05141019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Preemptive Pharmacogenetics in Underserved Patients
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2022
Completion date
June 30, 2026
Enrollment
492 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacogenetic testing, use of prescription medications